https://www.selleckchem.com/pr....oducts/Avasimibe(CI-
Innovations in vaccine product attributes could play an important role in addressing coverage and equity (CE) gaps, but there is currently a poor understanding of the full system impact and trade-offs associated with investing in such technologies, both from the perspective of national immunisation programmes (NIPs) and vaccine developers. Total Systems Effectiveness (TSE) was developed as an approach to evaluate vaccines with different product attributes from a systems perspective, in order to analyse and compare the va
Like
Comment
Share
